Atombeat and BioDuro Launch AI Platform for Peptide Drug Discovery
Atombeat and BioDuro have announced a strategic partnership to develop an AI-powered platform aimed at accelerating peptide drug discovery, as stated in a press release. The collaboration combines Atombeat's AI modeling expertise with BioDuro's chemistry and biology capabilities.